CorVel Corporation (CRVL)

Nasdaq Health Care Health Care Services S&P SmallCap 600
$83.16
-2.75 (-3.20%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Last report (Nov 03)
$0.67 vs — est.
Surprise —

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Nov 03, 2026Sep/2026—$0.67—

Our record of CRVL's reports since we began tracking; it grows each quarter.

Latest results, in brief

All CRVL 8-K briefs →
Nov 2, 7:30 PM ET

CorVel Q2 revenue rises 11% to $267 million; diluted EPS up 24% to $0.67

Positive earnings 2.02

CorVel reported results for the three months ended September 30, 2026, with revenue of $267 million, up from $240 million a year earlier, and diluted earnings per share of $0.67, up from $0.54. For the six months, revenue was $527 million and diluted EPS was $1.31, compared with $474 million and $1.06 a year earlier, and the company reported no borrowings at quarter end.

  • Quarter revenue of $267 million rose 11%; gross profit of $72.3 million, a 27% gross margin, compared with $58.2 million a year earlier
  • Quarter net income was $34.1 million, compared with $27.9 million in the prior-year quarter
  • Six-month revenue of $527 million and diluted EPS of $1.31, compared with $474 million and $1.06 a year earlier
  • Cash of $270 million and no borrowings at September 30, 2026; the company repurchased $18.1 million of common stock during the quarter
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$267.13M+11.5% $0.67+24.1% $34.09M12.8%
Jun 2026$259.93M+10.7% $0.63+21.2% $32.23M12.4%
Mar 2026$248.55M+7.4% $0.61+19.6% $31.03M12.5%
Dec 2025$235.62M+3.4% $0.47+2.2% $24.17M10.3%
Sep 2025$239.64M+6.8% $0.54+20.0% $27.91M11.6%
Jun 2025$234.71M+10.9% $0.52+23.8% $27.23M11.6%
Mar 2025$231.51M+11.7% $0.51-54.5% $26.42M11.4%
Dec 2024$227.97M+12.7% $0.46+39.4% $23.77M10.4%

From CorVel Corporation's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2026$958.53M+7.0% $2.14+16.9%11.5%
FY2025$895.59M+12.6% $1.83+24.5%10.6%
FY2024$795.31M+10.7% $1.47+16.7%9.6%
FY2023$718.56M+11.2% $1.26-65.6%9.2%
FY2022$646.23M+16.9% $3.66+43.5%10.3%

Frequently asked questions

When is CorVel's next earnings date?

CorVel has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did CorVel earn last quarter?

For the quarter ended Sep 2026, CorVel reported diluted EPS of $0.67 (+24.1% year over year) on revenue of $267.13M (+11.5%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.